The Role of Angiotensin in Obesity and Metabolic Disease

E-ISSN： 2212-3873|11|3|198-205

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.11, Iss.3, 2011-09, pp. : 198-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5267-5280

Bentham Science Publishers

Access to resources Recommend Favorite

The role of NPY in metabolic homeostasis: implications for obesity therapy

By Wieland H.A. Hamilton B.S. Krist B. Doods H.N.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1327-1346

Informa Healthcare

Access to resources Recommend Favorite

The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-01 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Renin-Angiotensin System in Cardiovascular Disease

By Cohn Jay

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 341-344

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems

By Ernsberger Paul Koletsky Richard

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 4, 2006-07 ,pp. : 245-258

Springer Publishing Company

Access to resources Recommend Favorite